BNP Paribas Financial Markets
ENZN

BNP Paribas Financial Markets’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

BNP Paribas Financial Markets’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-35
Closed -$38 – 3907
2014
Q3 		$38 Sell
35
-298
-89% -$368 ﹤0.01% 4069
2014
Q2 		$346 Buy
+333
New +$317 ﹤0.01% 3647
2014
Q1 		– Sell
-487
Closed -$565 – 4105
2013
Q4 		$565 Buy
+487
New +$750 ﹤0.01% 3924
2013
Q3 		– Sell
-12,593
Closed -$25.2K – 2822
2013
Q2 		$25.2K Buy
+12,593
New +$36.9K ﹤0.01% 2704

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BNP Paribas Financial Markets's ENZN Position: Q4 2014 in Review

BNP Paribas Financial Markets sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q4 2014, closing a stake of 35 shares — an estimated $38 sold.

BNP Paribas Financial Markets first reported a position in ENZN in Q2 2013 and held it in 4 quarters. The position peaked at $25.2K in Q2 2013. 57 funds tracked by Wall St. Rank hold ENZN as of Q4 2014.

  • BNP Paribas Financial Markets reported no remaining ENZON PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 35 ENZON PHARMACEUTICALS INC shares in Q4 2014, an estimated $38.
  • BNP Paribas Financial Markets first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • BNP Paribas Financial Markets's ENZON PHARMACEUTICALS INC position peaked at $25.2K in Q2 2013.
  • 57 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q4 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2014, filed 11 Feb 2015.